Followers | 144 |
Posts | 27709 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Thursday, October 20, 2005 2:01:24 PM
Predix was expected to raise $55 million on Nasdaq at a company value of $232 million.
Tali Tsipori 20 Oct 05 15:15
Israeli biotechnology company Predix Pharmaceuticals Holdings, which was scheduled to complete the pricing stage for its Nasdaq IPO last night, has apparently been forced to postpone it by one day. Predix was expected to raise $55 million at a company value of $211-253 million (average company value - $232 million). Trading in the company share will therefore begin tomorrow under the PRDX ticker symbol.
Predix will issue five million shares in the $10-12 price range. The underwriters -- UBS Investment Bank, Deutsche Bank Securities, ThinkEquity Partners LLC, and CIBC World Markets Corp. -- will receive an option to buy 750,000 more shares from the company, which would increase the proceeds by $8.3 million.
Predix focuses on the discovery and development of new drugs for treating diseases linked to G-Protein coupled receptors.
Published by Globes [online] - www.globes.co.il - on October 20, 2005
Dubi
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM